New Zealand Laws (Overview) — THC‑Free CBD 2025
This page summarizes New Zealand’s posture toward CBD, focused on products marketed as “THC‑free.” It is not legal or medical advice. Verify details with New Zealand’s Ministry of Health, Medsafe, the Medicinal Cannabis Agency (MCA), NZ Customs, and current Medicines and Misuse of Drugs frameworks. Reviewed through early 2025.
On this page
- Snapshot
- What “THC‑free” means (lab vs. policy)
- Access & supply (high level)
- Import, customs, and retail notes
- Testing, labeling, and documentation
- Travel and transit
- How to verify quickly
- Related resources
- FAQ
Snapshot
- Prescription framework: Many CBD products are treated as prescription medicines within the Medicinal Cannabis Scheme.
- Quality standards: Products supplied must meet New Zealand quality requirements; MCA sets minimum quality standard for medicinal cannabis products.
- Retail reality: General consumer OTC sale of CBD is not the norm; verify current status before assuming retail availability.
What “THC‑free” means (lab vs. policy)
“THC‑free” refers to a lab result—ND (not detected) for THC at the method’s LOQ on a COA. It is not, on its own, a legal classification for consumer sale. Classification and supply rules apply regardless of ND‑THC on the lab report.
Learn more: LOQ vs LOD, Verifying ND claims.
Access & supply (high level)
- Prescription supply: Doctors may prescribe CBD products that meet the minimum quality standard or otherwise permitted pathways. The MCA oversees product assessments.
- Product types: Oils, capsules, and certain other forms may be available under prescription; cosmetic/food positioning is restricted.
Import, customs, and retail notes
- Commercial import: Typically requires that products meet NZ standards and relevant permits/clearances. A THC‑free COA alone does not create an import pathway.
- Personal import: Rules change—historically limited quantities with a prescription have been discussed; confirm with Medsafe/NZ Customs before attempting.
- Retail: Do not assume non‑prescription retail availability. Check current MCA/Medsafe guidance.
Testing, labeling, and documentation
- Use batch‑matched third‑party COAs with cannabinoid profile (CBD, THC, THCA), ND/LOQ for THC, dates, lab details.
- Labels should clearly identify product, strength, batch/lot, and storage; medicinal products must meet applicable standards.
Travel and transit
Carry prescriptions and original packaging where applicable. When entering/exiting New Zealand, declare medicines as required and keep documentation ready. For general travel guidance, see the site’s Travel hub.
How to verify quickly
- Confirm the legal supply pathway (prescription vs consumer OTC).
- Review a current COA: confirm ND for Δ9‑THC (and THCA) at a stated LOQ.
- Match the COA batch/lot to the label; check dates and signatures.
Related resources
FAQ
Is CBD available without a prescription in New Zealand?
Treat most CBD as prescription‑only unless official guidance states otherwise.
Does ND‑THC on a COA change the legal status?
No. “THC‑free” is a lab outcome; classification still applies.
Can I bring CBD when traveling to NZ?
Verify with NZ Customs/Medsafe. Documentation (e.g., prescription) may be required and restrictions can apply.
Will THC‑free CBD affect a drug test?
Standard tests target THC metabolites, not CBD, but outcomes cannot be guaranteed. See overview.